[ASND] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
30-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -67.73%
YoY- -29.64%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 6,828 746 2,225 5,414 28 372 1,258 32.54%
PBT -125,257 -62,983 -63,394 -53,707 -41,482 -25,153 -20,636 35.04%
Tax 241 -191 -77 -70 -107 -14 -118 -
NP -125,498 -62,792 -63,317 -53,637 -41,375 -25,139 -20,518 35.21%
Tax Rate - - - - - - - -
Total Cost 132,326 63,538 65,542 59,051 41,403 25,511 21,776 35.06%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -1,837.99 -8,417.16 -2,845.71 -990.71 -147,767.86 -6,757.80 -1,631.00 2.01%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -2.21 -1.17 -1.32 -1.24 -1.07 -0.78 -0.82 17.95%
EPS Diluted -2.21 -1.17 -1.32 -1.24 -1.07 -0.78 -0.82 17.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.